Stevanato Group Reports Record 2021 Revenue of €843.9 million

08.03.2022 - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the fourth ...

Related Keywords

China ,Italy ,Indiana ,United States ,Canada ,United Kingdom ,Italian ,Franco Moro ,Franco Stevanato ,Italian Tax Agency ,Company Investor Relations ,Solutions Segment ,Company Annual Report On Form ,Development Expenses ,Exchange Commission ,Stevanato Group ,Chief Executive Officer ,Diagnostic Solutions Segment ,Executive Chairman ,European Time ,Financial Information ,Investor Relations ,Annual Report ,Marketing Expenses ,Administrative Expenses ,Constant Currency Revenue ,Adjusted Operating Profit ,Adjusted Operating Profit Margin ,Adjusted Diluted ,Capital Employed ,Free Cash ,Constant Currency ,Operating Profit ,Net Income ,Net Profit ,Financial Receivables ,New Plants ,